The chemical compounds selected target various aspects of calcium signaling and related pathways, providing multiple avenues through which the activity of CAPSL could be enhanced. Compounds like Calcium Ionophore A23187, Cyclopiazonic Acid, Thapsigargin, Ryanodine, and Ionomycin directly modulate intracellular calcium levels, a critical second messenger in numerous cellular processes. Given the ubiquitous nature of calcium signaling, it is plausible that CAPSL is sensitive to changes in calcium concentration, and thus its activity could be modulated indirectly through these compounds. BAPTA-AM's role as a calcium chelator allows for a nuanced approach in controlling calcium dynamics, offering another potential method to influence CAPSL activity.
Furthermore, compounds like PMA and Forskolin target specific enzymes like PKC and adenylyl cyclase, respectively, leading to altered downstream signaling cascades that could intersect with CAPSL's functional pathways. Okadaic Acid, through its inhibition of protein phosphatases, suggests a role in phosphorylation-based regulatory mechanisms, which are central to many signaling processes. The inclusion of calcium channel blockers such as Nitrendipine and Nifedipine adds another layer of complexity, as they could indirectly modulate CAPSL's activity by altering calcium influx, which is a crucial factor in numerous signaling pathways. Finally, Calmidazolium Chloride, by inhibiting calmodulin, provides insight into how calcium-dependent regulatory proteins might play a role in modulating CAPSL's activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which may activate calcium-dependent signaling pathways. If CAPSL is involved in these pathways, its activity could be enhanced by elevated calcium levels. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibits calcium ATPase in the sarcoplasmic and endoplasmic reticulum, leading to increased cytosolic calcium. This could activate CAPSL if it is sensitive to calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that raises cytosolic calcium levels. If CAPSL operates within calcium-dependent pathways, thapsigargin could indirectly enhance its activity. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulates the ryanodine receptor and alters calcium release from the endoplasmic reticulum, potentially affecting CAPSL if it is linked to calcium signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can be used to modulate intracellular calcium levels, influencing CAPSL activity if it is calcium-dependent. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC), which could influence CAPSL if it is part of or regulated by PKC-mediated signaling pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, potentially affecting CAPSL if it is involved in cAMP-dependent signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, potentially affecting CAPSL activity if it is regulated by phosphorylation-dephosphorylation mechanisms. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium concentration, potentially activating CAPSL if it is calcium-sensitive. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
A calcium channel blocker, which could indirectly affect CAPSL activity by altering calcium signaling pathways. | ||||||